Ogihara Shigeki, Tarnow Dennis P
Quintessence Int. 2015 Jun;46(6):481-90. doi: 10.3290/j.qi.a33936.
To determine the efficacy of enamel matrix derivative (EMD) and forced eruption alone or in combination with freeze-dried bone allograft (FDBA) or demineralized FDBA (DFDBA) when managing infrabony defects.
Seventy-four patients with an inadequate biologic width due to subgingival caries were randomly assigned to one of three intervention groups: Ortho/EMD/FDBA (OEF) (n = 25), Ortho/EMD/DFDBA (OED) (n = 24), and Ortho/EMD alone without graft material as a control (OE) (n = 25). Each patient donated an infrabony defect. The primary outcomes were absolute change in probing depth (PD) reduction and clinical attachment level (CAL) gain from baseline to 1- and 3-year follow-up. Infrabony defects were surgically treated with EMD/FDBA, EMD/DFDBA, or EMD alone 4 weeks before orthodontic extrusive force was applied to reestablish a biologic width of 2 mm.
Seventy-four patients (OEF, n = 25; OED, n = 24; OE, n = 25) were analyzed. All groups demonstrated significant improvement in PD reduction and CAL gain from baseline. The changes at 1 year for PD were: OEF (mm, 95% CI), 4.3, 3.7 to 4.7; OED, 4.2, 3.6 to 4.9; and OE, 3.4, 3.1 to 3.7; for CAL, changes were: OEF, 4.3, 3.9 to 4.7; OED, 3.9, 3.5 to 4.4; and OE, 3.3, 3.1 to 3.5. Longer follow-ups showed similar findings.
This study showed that both forced eruption/EMD/FDBA and forced eruption/EMD/DFDBA combination therapies result in greater soft tissue improvements at 1- and 3-year follow-up in addition to greater hard tissue improvements at 6-month re-entry compared with forced eruption/EMD alone.
确定釉基质衍生物(EMD)单独应用或与冻干异体骨(FDBA)或脱矿冻干异体骨(DFDBA)联合应用于处理骨下袋缺损时的疗效。
74例因龈下龋导致生物学宽度不足的患者被随机分配至三个干预组之一:正畸/EMD/FDBA(OEF)组(n = 25)、正畸/EMD/DFDBA(OED)组(n = 24)以及仅使用正畸/EMD作为对照且不使用移植材料的组(OE)(n = 25)。每位患者提供一个骨下袋缺损。主要观察指标为从基线到1年及3年随访时探诊深度(PD)减少的绝对变化以及临床附着水平(CAL)增加的情况。在施加正畸推挤力以重建2mm生物学宽度前4周,对骨下袋缺损分别采用EMD/FDBA、EMD/DFDBA或单独EMD进行手术治疗。
分析了74例患者(OEF组,n = 25;OED组,n = 24;OE组,n = 25)。所有组从基线到随访时的PD减少和CAL增加均有显著改善。1年时PD的变化为:OEF组(mm,95%CI),4.3,3.7至4.7;OED组,4.2,3.6至4.9;OE组,3.4,3.1至3.7;CAL的变化为:OEF组,4.3,3.9至4.7;OED组,3.9,3.5至4.4;OE组,3.3,3.1至3.5。更长时间的随访显示了类似的结果。
本研究表明,与仅采用正畸/EMD相比,正畸推挤力/EMD/FDBA和正畸推挤力/EMD/DFDBA联合治疗在1年及3年随访时除了在6个月再次进入时硬组织改善更大外,还能带来更大的软组织改善。